Latest Conference Articles

A 200 mg dose of the monoclonal antibody was also shown to significantly reduce ashtma exacerbations over 1 year versus placebo.

A retrospective review of rural region's hospitals found that even the discharge time of day could be associated with a greater chance of readmission.

Investigators from Brooke Army Medical Center discuss pharmacological and non-pharmacological treatment strategies for tobacco cessation.

Gram-negative bacteria excluding Pseudomonas Aeruginosa has been associated with greater rates of patient mortality, vasopressor administration, and ICU admission.

Investigators found that treating for CSA in the patient population significantly decreases mortality risk—despite previous clinical warnings.

Secondhand factors in asthma, such as environmental exposures like pets and secondhand smoke, are not significant in overall disease improvement.

Investigators have shared new disparities of characteristics in men and women with differing severities of respiratory arousal threshold.

Research indicates that influenza vaccine effectiveness was low but effective in preventing influenza-related hospitalization during the 2016-2017 flu season in Canada.

Investigators report the first real-world data on the safety and effectiveness of G/P for patients on opioid substitution therapy within the German Hepatitis C-Registry.

Keith Kaye, MD, MPH discusses the current successes and challenges in addressing multidrug-resistant infections, as well as expectations for how recommendations will change in the future.

Investigators find school-located influenza vaccination increased coverage and decreased school absence and influenza hospitalization.

Thomas Lodise, PharmD, PhD discusses the importance of practicing risk stratification and exploring combination therapeutic options in patients with drug-resistant infections.

Women are less likely to be administered lung protective tidal volumes (TVs) when being considered as a lung donor.

More IMPACT trial results shows Trelegy Ellipta has benefits for both reversible and nonreversible COPD patients in exacerbations and lung function versus dual therapy.

Data show that while women are underrepresented as fellows of the American College of Chest Physicians, the volume of women applying is increasing.

A new study found that Medicare Part D formulary shifts sometimes result in asthma patients forgoing controller therapy altogether.

In a Meet-the-Professors session at ID Week 2018, experts addressed strategies to check for drug-drug interactions, direct-acting antivirals for special populations, and the management of hepatitis C virus infection for persons who inject drugs.

Individuals with HIV who have been detained at the US border are far more likely to be released having had some consultation about their health and steps to improve their outlook compared with those who were detained several years ago.

New research suggests that flu vaccination setting is associated with vaccination timing.

A Dallas-based study found that an adult hospital with a universal screening policy was far more likely to provide screenings to high-risk patients aged 13 or older.

DOR/3TC/TDF demonstrates noninferior efficacy and safety compared with continuing other ART regimens in a phase 3 trial.

Kenneth Sherman, MD, PhD, discusses prevention measures for hepatitis B, managing co-infections of HIV and HCV, and recent developments to HCV screening processes

High-risk individuals, such as those with cardiopulmonary and other chronic conditions, are protected from flu-related hospitalizations with the vaccine.

Investigators analyzed data from PrEP-eligible patients at the New York City Health + Hospital/Bellevue which showed that women and minority patients were less likely to be prescribed PrEP for HIV prevention.

A South Korea meta-analysis found that, similarly to C. difficile, tuberculosis risk could be limited by the lipid-lowering agent.

Roche's investigative drug could become the first single-dose oral antiviral approved for the US market in December.

Community-onset cases still hovered around 45% of the annual cases, with the remainder being infections that developed once patients had been admitted to the hospital.

An oral influenza vaccine tablet protects against virus as well or better than an injectable quadrivalent vaccine in phase 2 trial.

Race and sex can play a role in the annual BMI gain for patients with HIV who are receiving certain antiretroviral therapy combinations.

Unvaccinated individuals can also benefit from the flu vaccine.